BioCryst Pharmaceuticals Inc BCRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:05 AM EDT
5.85quote price arrow up+0.22 (+3.91%)
Volume
535,699
52 week range
4.03 - 8.96
Loading...
  • Open5.72
  • Day High6.00
  • Day Low5.70
  • Prev Close5.63
  • 52 Week High8.96
  • 52 Week High Date06/08/23
  • 52 Week Low4.03
  • 52 Week Low Date04/25/24

Key Stats

  • Market Cap1.207B
  • Shares Out206.33M
  • 10 Day Average Volume4.24M
  • Dividend-
  • Dividend Yield-
  • Beta1.82
  • YTD % Change-1.84

KEY STATS

  • Open5.72
  • Day High6.00
  • Day Low5.70
  • Prev Close5.63
  • 52 Week High8.96
  • 52 Week High Date06/08/23
  • 52 Week Low4.03
  • 52 Week Low Date04/25/24
  • Market Cap1.207B
  • Shares Out206.33M
  • 10 Day Average Volume4.24M
  • Dividend-
  • Dividend Yield-
  • Beta1.82
  • YTD % Change-1.84

RATIOS/PROFITABILITY

  • EPS (TTM)-1.07
  • P/E (TTM)-5.48
  • Fwd P/E (NTM)-8.97
  • EBITDA (TTM)-88.125M
  • ROE (TTM)-1,925.37%
  • Revenue (TTM)355.395M
  • Gross Margin (TTM)98.56%
  • Net Margin (TTM)-58.69%
  • Debt To Equity (MRQ)-177.08%

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On BioCryst Pharmaceuticals Inc

 

Profile

MORE
BioCryst Pharmaceuticals, Inc. discovers oral and small-molecule medicines that treat rare diseases in which unmet medical needs exist and an enzyme plays the key role in the biological pathway of the disease. ORLADEYO (berotralstat) is an oral, once-daily therapy that is approved in the United States, the European Union, Japan, and the United Kingdom for the prevention of hereditary angioedema attacks in adults and pediatric patients 12 years and older. The Company has...
Nancy Hutson Ph.D.
Independent Chairman of the Board
Jon Stonehouse
President, Chief Executive Officer, Director
Anthony Doyle
Chief Financial Officer
Address
4505 Emperor Blvd Ste 200
Durham, NC
27703-8457
United States

Top Peers

SYMBOLLASTCHG%CHG
MDXG
MiMedx Group Inc
7.91+0.01+0.13%
KNSA
Kiniksa Pharmaceuticals Ltd
19.68+0.10+0.49%
VCYT
Veracyte Inc
23.53+1.03+4.58%
BEAM
Beam Therapeutics Inc
24.94+0.92+3.82%
MRVI
Maravai LifeSciences Holdings Inc
10.85+0.32+3.04%